Flucytosine Mechanism C ytosine permease ~ converted to 5-FU ~ FdUMP ( thymidylate synthase ) & FUTP ~ Inhibit DNA & RNA syn Spectrum Yeasts like Cryptococcus, Candida (+Amp) Chromoblasto (+ Itra ) Resistance ↓ ed enzymes or ↑ cyto syn (mono)
Pharmacokinetics & ADR Pharmacokinetics Good oral abs. Low PPB ~ Good dist. Inc. CSF ~ metabolized Urinary exc. (Amp) Adverse Effects Bone marrow toxicity (anemia, leukopenia , and thrombocytopenia) Hepatic dys ( abn LFT) Enterocolitis
Azoles Mechanism Inhibit C-14 demethylase ( Lano →Ergo ) CYP also inhibited Resistance Active efflux, target alteration/overproduction
Ketoconazole Pharmacokinetics Oral (Stomach, low pH) ~ high ppb ~ limited dist Hep meta ~ biliary exc. Spectrum Histoplasma , Blastomyces , Candida, and Coccidioides Adverse Effects Hypersensitivity GI Endocrine ( gynecomastia , decreased libido, impotence, and menstrual irregularities) Hepatitis Teratogenic Interactions Cyclosporine, phenytoin , tolbutamide , and warfarin Rifampin With Amph
Itraconazole Pharmacokinetics Oral/iv. Like keto . Poor dist. Abs. ↑ ed by low pH & food Hydroxy itra ~ urinary exc. does not affect mammalian steroid synthesis Spectrum B lastomycosis , sporotrichosis , paracoccidioidomycosis , and histoplasmosis Aspergillus Dermatophytoses and onychomycosis (DOC) ADR & Interactions GI, rash, hypokalemia , hypertension, edema, and headache Inhibits meta of drugs
Fluconazole Pharmacokinetics (Oral/iv) Good oral bioavailability ~ high water solubility & CSF dist. Abs. not dependent on low pH. Low ppb. Poor metabolism. Renal excretion. Spectrum Crypto (Post/Pre), Candida (systemic/ muco ), coccidioidomycosis ADR No endocrine. Nausea, vomiting, and rashes. Hepatitis CYP inhibition
Voriconazole Pharmacokinetics (Oral/iv) Good abs ~ Good dist inc. CSF. Hepatic meta Spectrum Aspergillosis Scedosporium apiospermum and Fusarium species ADR Visual (Prompt) Photosensitivity dermatitis (Chronic oral) rash and elevated hepatic enzymes Interaction (Inhibitor)
Echinocandins Caspofungin , micafungin , and anidulafungin Mechanism Inhibit β (1–3)- glucan Spectrum Candida and Aspergillus Pharmacokinetics Only iv Caspo has PPB ~ meta ~ exc by both fecal/urinary route
Adverse Effects ADR GI Histamine release Caspo shouldn’t be given in combination with cyclosporin ~ abnormal LFT’s.
Griseofulvin rption with fatty food. DepoInsoluble fungistatic Good absosited in skin ~ binds to keratin ~ mitotic spindle and inhibition of fungal mitosis. Used systemically for tineas . For skin ~ 2-6 weeks therapy. For nails ~ months Adverse effects inc. allergic syndrome much like serum sickness, hepatitis, and drug interactions with warfarin and phenobarbital .
Terbinafine Fungicidal, effective orally, keratophilic Interferes with ergo syn. by inhibiting the enzyme squalene epoxidase ~ squalene acc. Only effective orally ~ 1 st pass ~ meta by CYP (Rif/ Cim ) ~ urinary exc. Dermatophytosis esp. onychomycosis . GI, headache, rash, taste/visual dist, abn . LFT’s
Topical Antifungals Nystatin Polyene macrolide . Only for candida Azoles ( Clo / Mico ) Candida Ketoconazole topical/shampoo for seborrheic dermatitis and pityriasis versicolor Allylamine Terbinafine and naftifine topical creams for tinea ( cruris , corporis ) ADR Limited to local irritation, dermatitis, edema.